Xometry (NASDAQ:XMTR) President Sanjeev Singh Sahni Sells 9,978 Shares

Xometry, Inc. (NASDAQ:XMTR) President Sanjeev Singh Sahni sold 9,978 shares of the firm’s stock in a transaction dated Thursday, February 26th. The shares were sold at an average price of $43.45, for a total transaction of $433,544.10. Following the transaction, the president directly owned 113,022 shares in the company, valued at $4,910,805.90. This trade represents a 8.11% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Sanjeev Singh Sahni also recently made the following trade(s):

• On Thursday, January 8th, Sanjeev Singh Sahni sold 26,190 shares of Xometry stock. The stock was sold at an average price of $65.47, for a total transaction of $1,714,659.30.
• On Monday, January 5th, Sanjeev Singh Sahni sold 4,446 shares of Xometry stock. The shares were sold at an average price of $66.57, for a total transaction of $295,970.22.

Xometry Stock Performance

Shares of NASDAQ:XMTR opened at $45.26 on Friday. The firm has a 50 day moving average of $61.06 and a 200 day moving average of $56.04. The company has a quick ratio of 3.58, a current ratio of 3.76 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $2.32 billion, a price-to-earnings ratio of -37.10 and a beta of 0.86. Xometry, Inc. has a 52 week low of $18.59 and a 52 week high of $73.87.

Xometry (NASDAQ:XMTR) last announced its earnings results on Tuesday, February 24th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.04. The business had revenue of $192.40 million for the quarter, compared to analysts’ expectations of $183.37 million. Xometry had a negative return on equity of 5.49% and a negative net margin of 8.99%.The business’s revenue for the quarter was up 29.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.06 EPS. On average, sell-side analysts predict that Xometry, Inc. will post -0.66 earnings per share for the current fiscal year.

Trending Headlines about Xometry

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Citi and Wedbush remain constructive on Xometry despite trimming targets — Citi keeps a “buy” rating (target cut to $65) and Wedbush keeps an “outperform” rating (target cut to $60); these sustained bullish ratings temper the negative headlines and signal some analysts still see upside. Xometry (NASDAQ:XMTR) Price Target Cut to $65.00 by Analysts at Citigroup
• Positive Sentiment: Valuation story after strong 2025 results: a recent Yahoo piece assesses Xometry’s valuation in light of solid 2025 revenue growth and an upcoming CEO transition — this frames the company as still fundamentally improving even amid near-term noise. Assessing Xometry (XMTR) Valuation After Strong 2025 Results And Upcoming CEO Transition
• Neutral Sentiment: UBS nudged its target to $55 with a “neutral” rating — a modest change that neither strongly supports nor condemns near-term price action. Xometry (NASDAQ:XMTR) Given New $55.00 Price Target at UBS Group
• Neutral Sentiment: Royal Bank of Canada cut its target to $55 and now lists Xometry as “sector perform” — another mixed signal that reduces consensus upside but isn’t a full-scale downgrade. Xometry (NASDAQ:XMTR) Price Target Cut to $55.00 by Analysts at Royal Bank Of Canada
• Negative Sentiment: Market reaction / analyst downgrade headline — outlets reported Xometry trading down after analyst downgrades/target cuts, contributing to today’s weakness in the stock. Xometry (NASDAQ:XMTR) Trading Down 7.3% After Analyst Downgrade
• Negative Sentiment: Large insider sales by multiple senior executives (CEO, CFO, President, CTO and others) were disclosed on Feb. 26 — sizable, contemporaneous insider selling typically raises investor concern about insider sentiment and adds pressure to the share price. SEC filing (CEO sale) linked for reference. SEC filing – CEO sale
• Negative Sentiment: Reported Q4/2025 earnings call transcript excerpts were circulated saying Xometry missed EPS expectations — if investors treat those reports as accurate, they amplify downside pressure despite other outlets reporting a beat; the earnings narrative remains a source of confusion and volatility. Xometry, Inc. (NASDAQ:XMTR) Q4 2025 Earnings Call Transcript

Wall Street Analyst Weigh In

Several analysts have commented on XMTR shares. Cantor Fitzgerald increased their price target on shares of Xometry from $41.00 to $60.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Zacks Research cut shares of Xometry from a “hold” rating to a “strong sell” rating in a research report on Friday, January 30th. Weiss Ratings restated a “sell (e+)” rating on shares of Xometry in a research note on Wednesday, January 21st. The Goldman Sachs Group lifted their price target on shares of Xometry from $49.00 to $56.00 and gave the stock a “neutral” rating in a report on Wednesday, November 5th. Finally, JPMorgan Chase & Co. increased their price objective on Xometry from $55.00 to $70.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Five analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $62.00.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Sylebra Capital LLC raised its holdings in shares of Xometry by 9.6% in the second quarter. Sylebra Capital LLC now owns 2,062,157 shares of the company’s stock worth $69,680,000 after buying an additional 180,533 shares during the last quarter. Ameriprise Financial Inc. raised its stake in Xometry by 54.2% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,964,909 shares of the company’s stock worth $107,029,000 after acquiring an additional 690,558 shares during the last quarter. First Trust Advisors LP lifted its position in Xometry by 9.2% during the 4th quarter. First Trust Advisors LP now owns 1,576,075 shares of the company’s stock worth $93,729,000 after acquiring an additional 132,792 shares during the period. Baillie Gifford & Co. lifted its position in Xometry by 1.6% during the 4th quarter. Baillie Gifford & Co. now owns 1,306,151 shares of the company’s stock worth $77,677,000 after acquiring an additional 20,901 shares during the period. Finally, Fuller & Thaler Asset Management Inc. purchased a new stake in Xometry during the 4th quarter valued at about $76,393,000. Institutional investors and hedge funds own 97.31% of the company’s stock.

Xometry Company Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.